We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

23 hedge funds and large institutions have $23.1M invested in vTv Therapeutics in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

164% more capital invested

Capital invested by funds: $8.74M → $23.1M (+$14.3M)

15.33% more ownership

Funds ownership: 22.43% → 37.76% (+15%)

10% more funds holding

Funds holding: 21 → 23 (+2)

Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
+$2.94M
2
SL
Siren LLC
Connecticut
+$2.86M
3
BBA
Baker Bros. Advisors
New York
+$895K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$258K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$66.9K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$37K
2
Northern Trust
Northern Trust
Illinois
-$21.3K
3
Bank of America
Bank of America
North Carolina
-$193
4
Raymond James Financial
Raymond James Financial
Florida
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
SB
1
Samsara BioCapital
California
$8.74M +$2.94M +167,677 +81%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$4.49M +$258K +14,691 +8%
SL
3
Siren LLC
Connecticut
$3.81M +$2.86M +163,000 New
BBA
4
Baker Bros. Advisors
New York
$3.46M +$895K +51,000 +52%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.09M +$66.9K +3,815 +9%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$356K +$42.7K +2,432 +19%
Northern Trust
7
Northern Trust
Illinois
$329K -$21.3K -1,215 -8%
Millennium Management
8
Millennium Management
New York
$301K -$37K -2,107 -14%
CCM
9
Connective Capital Management
California
$227K – – –
BlackRock
10
BlackRock
New York
$115K +$1.9K +108 +2%
UBS Group
11
UBS Group
Switzerland
$69.3K +$2.16K +123 +4%
Osaic Holdings
12
Osaic Holdings
Arizona
$37.2K +$25.4K +1,450 +853%
Morgan Stanley
13
Morgan Stanley
New York
$17.4K – – –
SFCL
14
Strengthening Families & Communities LLC
Massachusetts
$4.04K +$3.04K +173 New
AWM
15
Activest Wealth Management
Florida
$1.17K – – –
CA
16
CoreCap Advisors
Michigan
$1.05K – – –
PA
17
Parallel Advisors
California
$887 – – –
SS
18
Sunbelt Securities
Texas
$350 – – –
BNP Paribas Financial Markets
19
BNP Paribas Financial Markets
France
$210 – – –
SS
20
SBI Securities
Japan
$47 – – –
Bank of America
21
Bank of America
North Carolina
$23 -$193 -11 -92%
SWP
22
Strategic Wealth Partners
Ohio
$23 – – –
Citigroup
23
Citigroup
New York
$23 +$18 +1 New
Raymond James Financial
24
Raymond James Financial
Florida
– -$15 -1 Closed

VTVT Hedge Fund Activity: Q3 2025 in Review

23 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q3 2025, worth a combined $23.1M — up 164% from $8.74M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VTVT positions and 1 closed out — a net gain of 2 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was Samsara BioCapital, adding an estimated $2.94M. The largest seller was Millennium Management, cutting an estimated $37K.

  • 23 institutional investors held vTv Therapeutics (VTVT) as of Q3 2025, up from 21 in Q2 2025.
  • Funds reported $23.1M of vTv Therapeutics stock for Q3 2025, up 164% quarter-over-quarter.
  • 3 funds opened new vTv Therapeutics positions in Q3 2025 and 1 closed out, a net change of +2 holders.
  • The largest vTv Therapeutics buyer in Q3 2025 was Samsara BioCapital, an estimated $2.94M added.
  • The largest vTv Therapeutics seller in Q3 2025 was Millennium Management, an estimated $37K sold.

Based on aggregated 13F filings for Q3 2025.